Home
>
National Drug Code (NDC)
>
RANITIDINE
RANITIDINE - 57664-141-34 - (RANITIDINE)
Drug Information of RANITIDINE
| Product NDC: | 57664-141 |
| Proprietary Name: | RANITIDINE |
| Non Proprietary Name: | RANITIDINE |
| Active Ingredient(s): | 15 mg/mL & nbsp; RANITIDINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SYRUP |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RANITIDINE
| Product NDC: | 57664-141 |
| Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091091 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111003 |
Package Information of RANITIDINE
| Package NDC: | 57664-141-34 |
| Package Description: | 473 mL in 1 BOTTLE (57664-141-34) |
NDC Information of RANITIDINE
| NDC Code | 57664-141-34 |
| Proprietary Name | RANITIDINE |
| Package Description | 473 mL in 1 BOTTLE (57664-141-34) |
| Product NDC | 57664-141 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | RANITIDINE |
| Dosage Form Name | SYRUP |
| Route Name | ORAL |
| Start Marketing Date | 20111003 |
| Marketing Category Name | ANDA |
| Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
| Substance Name | RANITIDINE HYDROCHLORIDE |
| Strength Number | 15 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
